{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:57Z","timestamp":1791295617174,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5517,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.exphem.2007.01.053","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T05:44:05Z","timestamp":1180071845000},"page":"702-711","source":"Crossref","is-referenced-by-count":164,"title":["V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules"],"prefix":"10.1016","volume":"35","author":[{"given":"Anna","family":"Falanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Vignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Guerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2007.01.053_bib1","series-title":"Textbook of Malignant Hematology","first-page":"847","article-title":"Chronic myeloid disorders, excluding CML","author":"Barbui","year":"1999"},{"key":"10.1016\/j.exphem.2007.01.053_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythemia vera and essential thrombocythemia","volume":"128","author":"Elliot","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed over 20 years","volume":"123","author":"Gruppo Italiano Studio Policitemia (GISP)","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2007.01.053_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/09537100310001646969","article-title":"Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera","volume":"15","author":"Michiels","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/j.exphem.2007.01.053_bib5","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera","volume":"15","author":"Landolfi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.01.053_bib6","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","article-title":"Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors and Jak2 mutation status","volume":"15","author":"Carobbio","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.01.053_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/asheducation.V2005.1.409.409","article-title":"Platelets and thrombosis in myeloproliferative disorders","author":"Harrison","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.exphem.2007.01.053_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2005.05.023","article-title":"Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils","volume":"42","author":"Falanga","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.exphem.2007.01.053_bib11","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.01.053_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","article-title":"Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera","volume":"33","author":"Falanga","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2007.01.053_bib14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2007.01.053_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2007.01.053_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2007.01.053_bib17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2007.01.053_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskkyj","year":"2006","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.exphem.2007.01.053_bib19","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2007.01.053_bib20","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"Passamonti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.01.053_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2249.2005.02963.x","article-title":"Cellular inflammatory response to persistent localized Staphylococcus aureus infection: phenotypical and functional characterization of polymorphonuclear neutrophils (PMN)","volume":"143","author":"Wagner","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.exphem.2007.01.053_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1160\/TH06-10-0581","article-title":"Formation of mixed platelet-PMN leukocyte aggregates in the platelet function analyzer (PFA-100) device","volume":"97","author":"Maugeri","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1309\/K58EWK4HPD51U3BE","article-title":"Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100","volume":"123","author":"Cesar","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.exphem.2007.01.053_bib24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.exphem.2007.01.053_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1096\/fj.02-0574fje","article-title":"Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets","volume":"17","author":"Muller","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.exphem.2007.01.053_bib26","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.ATV.0000085629.23209.AA","article-title":"Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs","volume":"23","author":"Camera","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.exphem.2007.01.053_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/09537100220146398","article-title":"The presence and release of tissue factor from human platelets","volume":"13","author":"Siddiqui","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.exphem.2007.01.053_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-2141.2000.02030.x","article-title":"Increased platelet activation and abnormal glycoprotein content and redistribution in myeloproliferative disorders","volume":"110","author":"Jensen","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2141.2004.05032.x","article-title":"P-selectin in haemostasis","volume":"126","author":"Andr\u00e9","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molmed.2004.02.008","article-title":"Role of platelet P-selectin and microparticles PSGL-1 in thrombus formation","volume":"10","author":"Furie","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.exphem.2007.01.053_bib31","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"Links The P-selectin, tissue factor, coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.1989.tb07755.x","article-title":"Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb\/IIIa complex is associated with deficient receptor function","volume":"73","author":"Mazzucato","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.1995.tb05357.x","article-title":"Increased platelet CD36 constitutes a common marker in myeloproliferative disorders","volume":"91","author":"Thibert","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.01.053_bib34","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20021868","article-title":"Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin","volume":"197","author":"Falati","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2007.01.053_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0741-5214(03)01033-4","article-title":"P-selectin and leukocyte microparticles are associated with venous thrombogenesis","volume":"38","author":"Myers","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.exphem.2007.01.053_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood.V96.1.170","article-title":"Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor","volume":"96","author":"Rauch","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.01.053_bib37","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/j.1538-7836.2005.01603.x","article-title":"Links Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity","volume":"3","author":"Barnard","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0037-1613922","article-title":"Tissue factor in neutrophils","volume":"83","author":"Nemerson","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1538-7836.2004.00548.x","article-title":"Tissue factor in neutrophils: yes","volume":"2","author":"Nakamura","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1538-7836.2004.00546.x","article-title":"Tissue factor in neutrophils: no","volume":"2","author":"Osterud","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib41","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1538-7836.2006.02194.x","article-title":"Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?","volume":"4","author":"Maugeri","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1538-7836.2006.01968.x","article-title":"Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation","volume":"4","author":"Maugeri","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2007.01.053_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/hcg037","article-title":"Assessment of endothelial damage and dysfunction: observations in relation to heart failure","volume":"96","author":"Chong","year":"2003","journal-title":"QJM"}],"updated-by":[{"DOI":"10.1016\/j.exphem.2007.07.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000}}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:55:13Z","timestamp":1654919713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X07000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0301472X07000975"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2007.01.053","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}